Poster

Avapritinib Decreased Symptom Burden in Patients With Indolent Systemic Mastocytosis in the Registrational Double-Blind, Placebo-Controlled PIONEER Study

Author

Matthew P. Giannetti

Condition

Indolent Systemic Mastocytosis

Source url

s3://convoke-optic-posters/2024-05-10/Blueprint-Medicines-AAAAI-2024-Avapritinib-PIONEER-Study-Indolent-Systemic-Mastocytosis-Decreased-Symptom-Burden-Poster.pdf

1 organization

1 product

Product

Avapritinib

Organization

Blueprint Medicines